Immediate action required

I am writing to let you know that your $300 MarketBeat account credit is expiring in less than 12 hours. Unsubscribe Greetings, I am writing to let you know that your $300 MarketBeat account credit is expiring in less than 12 hours. Over a hundred of your fellow MarketBeat subscribers have upgraded to MarketBeat All Access Pass in the last few days (and have gotten a great deal on their subscription). Unfortunately, you haven't taken action yet. We are making the first month of MarketBeat All Access available for FREE for anyone that registers tonight by 11:59 PM Pacific Time. If you want to continue your subscription after your first month, you'll still receive the $300 discount on your first year's subscription ($99.00 instead of $399.00). Make the Move - Upgrade to MarketBeat All Access for Free Why Upgrade to MarketBeat All Access? Access Award-Winning Research Tools - MarketBeat All Access offers a full suite of modern stock research and portfolio monitoring tools backed by comprehensive financial datasets that you can't get anywhere else. MarketBeat tracks more than two million market events and news stories each year, creating an unrivaled ability to provide accurate, complete, and up-to-the-minute financial information. Cut Through the Noise - Equities research analysts issue more than 175,000 distinct "Buy" and "Sell" recommendations each year. After tracking the ROI of following analyst recommendations for nearly a decade, we know which analysts you should pay attention to and which you can safely ignore. With your All Access subscription, you'll get access to our list of top-rated and most-accurate brokers as well as their most recent "Buy" and "Sell" recommendations. Real-Time Data for Timely Trades - You will be among the first to receive your daily newsletter and instant email and SMS alerts for important market events. You won't need to scour through dozens of different websites to find news relevant to your stocks. Use MarketBeat All Access to get ratings, earnings, dividends, insider trades, and headlines delivered to your inbox automatically, every day. Save $300 on an All Access Pass Subscription (Ends Tonight!) Rebecca McKeever MarketBeat P.S. This offer is only available through 11:59 PM Pacific tonight. Take action now! Register Here for MarketBeat All Access (Free for 30 Days!) Thank you for subscribing to DividendStocks.com's daily newsletter for dividend and income investors that covers ex-dividend stocks, new dividend declarations, dividend stock ideas, and the latest market news.   If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.   If you no longer wish to receive email from DividendStocks.com, you can unsubscribe.   © 2006-2023 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103. United States.   Today's Bonus Content: The single greatest medical breakthrough of all time?